Irvine, CA—Nov. 3, 2022 Scalable data management solution to drive clinical efficiency, improve workflow, and aide clinicians in patient management Modulim, a health technology company

Irvine, CA—July 12, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announces a strategic

Irvine, CA—July 6, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announced today that

Irvine, CA—May 10, 2022— Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives announces the appointment of Carl

Irvine, CA—April 19, 2022— Irvine, CA—April 19, 2022—Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives, announces

Irvine, CA—July 2021 The UCI Beall Applied Innovation Center recognized Modulim CTO and Founder David Cuccia in a recent article on successful startups. Learn more

Irvine, CA—June 28, 2021 Modulim, provider of optical imaging solutions that incorporate its patented spatial frequency domain imaging (SFDI) technology to transform healthcare and help

Irvine, CA—May 12, 2021 Modulim’s CEO, Charlie Huiner, will be presenting at this year’s LSI 2021 Emerging Medtech Summit in Dana Point, CA May 11th-13th 2021.

Irvine, CA—April 1, 2021 Tissue flaps are commonly used in limb salvage to heal wounds and prevent amputations. Patients with advanced peripheral arterial disease (PAD),

Irvine, CA—March 8, 2021 In a recent case series published in the BMJ Open Diabetes Research & Care journal, a clinical research team lead by

Irvine, CA—February 1, 2021 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today the results

Modulated Imaging (dba Modulim) was recently highlighted by National Institute of Aging (NIA) as a showcase company. Modulim successfully completed a Phase 2 Small Business Innovation Research

Irvine, CA–January 11-15, 2021 Modulim is participating in Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™ 2021, and providing an on-demand company presentation.

Irvine, CA—December 8, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, today announced that Charles

Irvine, CA—December 2, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi® has received

August 17, 2020 Modulim currently has over 500 attendees signed up for a one-hour CME lecture “What is Spatial Frequency Domain Imaging and Why We

July 1, 2020 Check out this article detailing research using optical technologies to help manage soldiers health on battlefield. We are grateful to partner with the Beckman

June 29, 2020 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced that Dr. Anand Patel,

June 22, 2020 Modulim will exhibit a virtual booth at The Western Foot and Ankle Conference on June 26 and 27, 2020. SFDI will be

April 6, 2020 Modulim hit an internal milestone this month. In partnership with our clinical partners, we have acquired over 3000 images of feet using

February 3, 2020 Modulim’s new proprietary CPT code 0061U was highlighted by Kathleen Schaum, in Today’s Wound Clinic. The code can be used for capturing five

January 28, 2020 Modulim’s VP of R&D Amaan Mazhar will be presenting an invited talk at the Molecular Guided Surgery Conference at Photonics West 2020

January 15 – 19, 2020 Disney’s Coronado Springs Resort. As a Gold Sponsor of APMA, Modulim will be hosting a NON-CECH Lunch and Learn from

Modulim is a proud sponsor and corporate associate of the American Podiatric Medical Association (APMA):

Irvine, CA — July 30, 2019 (BUSINESS WIRE) — Modulim, the global leader in noninvasive microvascular assessment using spatial frequency domain imaging (SFDI), has announced that

July 2019 The Journal of Biomedical Optics recently featured a special section on Spatial Frequency Domain Imaging (SFDI). Our founder & CTO, David Cuccia, and our VP

Salt Lake City, UT — July 11, 2019 —  Modulim, recognized leader in optical imaging solutions for the noninvasive assessment of tissue health, will showcase

Modulim, a recognized leader in optical imaging solutions for the non-invasive assessment of tissue health, exhibited its ClarifiTM Imaging System at this year’s 2019 Western Foot and

Irvine, CA—June 25, 2019— Modulim, recognized leader in optical imaging solutions for the noninvasive assessment of tissue health, is pleased to announce that it has

New Orleans, LA—May 29, 2019— Modulim, recognized leader in optical imaging solutions for non-invasive assessment of tissue health, will exhibit its Clarifi™ Imaging System this week

The 8th International Symposium on the Diabetic Foot (ISDF), held every four years, took place last week from May 22-25 at The Hague in the Netherlands. As

San Antonio, TX—May 7, 2019— Conference Will Feature First Public Demo of Innovative Technology Modulim, recognized leader in optical imaging solutions for non-invasive assessment of

IRVINE, Calif.–April 23, 2019 – (BUSINESS WIRE)– Modulim, a recognized leader in SFDI-based optical imaging solutions for the non-invasive assessment of tissue health, has announced the findings

IRVINE, Calif. — March 5, 2019 (BUSINESS WIRE) — Company Moves to Larger Headquarters and Expands Team as it Prepares for Commercialization of Clarifi™ Imaging System

Irvine, CA—January 23, 2019— First close of $10M round to fund commercialization of Clarifi™ and additional clinical studies Modulated Imaging, recognized leader in optical imaging

IIrvine, CA — July 31, 2018 — Modulated Imaging, the leader in optical imaging solutions powered by Spatial Frequency Domain Imaging (SFDI) for non-invasive assessment

IRVINE, CA – May 1, 2018 Modulated Imaging, the leader in optical imaging solutions powered by Spatial Frequency Domain Imaging (SFDI) for noninvasive assessment of

Irvine, CA – November 15, 2017 Modulated Imaging, Inc., announced today that it has closed a $2.86 million Series A financing round to support growing

Irvine, CA – January 18, 2017 Modulated Imaging, Inc. announced today that it has received clearance from the FDA for its Ox-Imager CS technology. This

Irvine, CA—October 28, 2016 Modulated Imaging received the Orange County (OC) Tech Alliance 2016 Medical Device Innovation Award at the 23rd Annual OC Tech Alliance Award

Irvine, CA—August 04, 2016 Modulated Imaging announced today that they have been awarded a $1.8 million SBIR Phase II grant by the National Institutes of

Irvine, CA – July 25, 2016 Modulated Imaging has announced that it has secured an initial $500,000 seed round of financing. This equity round represents

August 3, 2015 Modulated Imaging is now open for business in our new facility, located in the heart of the Irvine Business District. For the

November 18, 2014 Modulated Imaging learned today that the United States Patent and Trademark Office has issued US Patent 8,892,192 covering important updates to the

October 31, 2014 Rice University’s Department of Bioengineering announced that Amaan Mazhar, Ph.D. was one of three recipients of its Alumni of the Year Award.

August 13, 2013 Today, Modulated Imaging is proud to announce that the United States Patent and Trademark Office has issued US Patent 8,509,879 covering apparatus

June 5, 2013 Modulated Imaging is excited to share that we have been awarded a Small Business Innovation Research Phase II Grant (9R44AR064657) from the

September 24, 2012 This week, Modulated Imaging was awarded a Small Business Innovation Research Phase II Grant (W81XWH-11-C-108) from the US Army Medical Research, part

The American Society For Laser Medicine & Surgery (ASLMS) announced today that Modulated Imaging co-founder and CEO David Cuccia, Ph.D., has been awarded the 2012

September 15, 2011 Modulated Imaging is proud to announce that we have been awarded a Small Business Technology Transfer Phase II Grant (2R42GM077713) from the